Prescribing compounded drugs and telehealth, state by state

State rules for compounded drugs

No state list of allowed or banned substances found. Rule 680-X-2-.43 says compounding pharmacies "shall comply with all applicable and current regulations of United States Pharmacopeia" (USP-NF). Federal 503A/503B rules apply. (A confidence: high)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1

State rules for compounded drugs

Stricter than federal. 12 AAC 52.440 requires following the board pamphlet "Compounding Practices" (Feb 2008), printed in the state licensing division's pharmacy statutes and regulations file. Pamphlet (c): when a compounded product replaces a commercially available one, "both the patient and the prescribing practitioner must authorize the use of the compounded product." Pamphlet (d): "A pharmacist may not offer compounded drug products to prescribing practitioners, pharmacists, or pharmacies for resale except in the course of professional practice for a prescribing practitioner to administer to an individual patient." The board file is a state copy that says the official Alaska Statutes control, and 12 AAC on akleg.gov was not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with conditions, for drugs that are not controlled. AS 08.64.364(a): the board may not discipline a physician for prescribing without a physical exam if follow-up care is available and the patient is offered a copy of records sent to their primary care provider. Controlled drugs must also meet AS 08.64.363. No prescribing from an internet questionnaire or email to a person with no prior physician-patient relationship (364(c)(2)). 12 AAC 40.943 adopts the 2014 FSMB telemedicine model policy as the standard.

Where the prescriber must be licensed

Yes. AS 08.64.170(a): no one may practice medicine in Alaska without a license under that chapter. Interstate compact paths exist (AS 08.64.253, 254). The old exception in 08.64.170(a)(1) was repealed in 2026. (C confidence: medium, read in the licensing division copy, not the official code)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

No state list of allowed or banned substances found. A.A.C. R4-23-410(A) requires compounding "in compliance with applicable federal and state law." R4-23-410(B)(1) requires ingredients that meet compendium standards, or are CP, AR, ACS, or FCC grade, or come from a source the pharmacist judges acceptable. (A confidence: high)

Telehealth before an in-person visit

Yes, with conditions. ARS 32-1401(27)(tt): a licensee may not prescribe without first doing a physical or mental health exam or having an existing physician-patient relationship, and "the ... examination may be conducted through telehealth" with a clinical evaluation appropriate for the patient and condition.

Where the prescriber must be licensed

Arizona license, or out-of-state telehealth registration under ARS 36-3606 (register with the Arizona board, unrestricted license elsewhere, malpractice insurance, drug-monitoring program registration before prescribing controlled drugs, follow Arizona law). (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

No state list of allowed or banned substances found. 17 CAR 160-2201(d) (effective June 29, 2026) requires full compliance with section 503A and USP compounding chapters. 160-2201(b) generally bans copying a commercially available FDA-approved drug, except for a documented patient-specific need or documented unavailability. (A confidence: high)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

No state list found in the statute read. B&P 4126.8: compounding "shall be consistent with standards established in the pharmacy compounding chapters of the current version of the United States Pharmacopeia-National Formulary," and the board may add standards. The board's rules (16 CCR 1735 and after) were not read. (A confidence: medium)

Telehealth before an in-person visit

Yes. B&P 2242(a): "An appropriate prior examination does not require a synchronous interaction ... and can be achieved through the use of telehealth, including, but not limited to, a self-screening tool or a questionnaire," if the standard of care is met. B&P 2290.5(b): the patient's consent to telehealth must be obtained and documented.

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

No state list of allowed or banned substances found. 3 CCR 719-1 Rule 21.00 covers compounding. Rule 21.10.60 requires certificates of analysis for ingredients that are not FDA-approved. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Colorado license, or registration as an out-of-state telehealth provider under C.R.S. 12-30-124 (added by SB24-141). 12-30-124(3): a regulator may register an applicant with no Colorado license who holds an active, unencumbered out-of-state credential, names an agent in Colorado, and meets the insurance rule. 12-30-124(11): "A registered provider shall not prescribe a controlled substance." (C confidence: medium, read in the signed bill text, not the compiled current statute)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. CGS 20-633b(b)(1)(A): a pharmacy that intends to compound sterile drugs must file a license addendum, the department inspects the premises, and the pharmacy "shall not compound sterile pharmaceuticals until" it gets notice that the addendum was approved. 20-633b(c): "A sterile compounding pharmacy shall comply with the USP chapters" 797, 800 and 825. Nonsterile compounding rules were not read. (A confidence: medium) Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it.

Telehealth before an in-person visit

Yes, with conditions. CGS 19a-906(b)(1): a telehealth provider may treat using real-time two-way or store-and-forward technology if they have the patient's medical history and record, meet the in-person standard of care, and give the patient their license number. No in-person-first rule found. 19a-906(c) bans telehealth prescribing of Schedule I to III controlled drugs, with narrow exceptions.

Where the prescriber must be licensed

Yes. A "telehealth provider" must hold a Connecticut license under title 20. The temporary out-of-state exception covered only mental and behavioral health and ended June 30, 2025. (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. 24 Del. C. 2502(26): an outsourcing facility must be "licensed with the Board as a wholesaler" and "licensed with the Board as an outsourcing facility" on top of its FDA registration. 2502(7): "All compounding must comply with applicable United States Pharmacopeia" standards. The Delaware rule 24 Del. Admin. Code 2500 could not be saved (script-only site), so rule-level limits are not read. (A confidence: medium) Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it.

Telehealth before an in-person visit

Yes, with conditions. 24 Del. C. 6003(a): a provider-patient relationship may be set up in person or by telehealth, and must include identity and location checks, disclosure of credentials, informed consent, a diagnosis by accepted methods, discussion of options, follow-up coverage, and a written visit summary. 6003(c): no prescribing only from an internet questionnaire, internet consult, or phone consult without a proper relationship. 6004(a)(3) allows diagnosis by audio or visual communication.

Where the prescriber must be licensed

Delaware license, or an interstate telehealth registration from the Division of Professional Regulation if licensed in a state with no applicable compact (24 Del. C. 6002(c)). (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

22-B DCMR 1901.4: "A pharmacy shall stock, maintain, sell, compound, dispense, and distribute only FDA registered drugs, medical devices, and chemicals for compounding." The text read does not define "FDA registered" for bulk ingredients. (A confidence: medium)

Telehealth before an in-person visit

Yes, with conditions. DC Code 3-1201.05(b): a practitioner-patient relationship may be set up by telehealth under the standard of care, but the Mayor may require an initial in-person exam for specific professions by rule. 17 DCMR 4618 (physician telehealth rule) was not read.

Where the prescriber must be licensed

DC license required. Exceptions: an existing relationship where the patient is temporarily in DC, or is a DC resident and care lasts no more than 120 days; interstate compacts also apply (3-1201.05(e), (f)). (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

No separate state list. Rule 64B16-27.700(4): human compounding "must strictly adhere to relevant federal regulations, including but not limited to 21 USC 353a and 21 USC 353b." Sterile compounding also follows 64B16-27.797. (A confidence: high)

Telehealth before an in-person visit

Yes. Fla. Stat. 456.47(2)(b): if a telehealth evaluation is enough to diagnose and treat, no prior medical-history research or physical exam is required. 456.47(2)(c): no telehealth prescribing of Schedule II drugs except for listed cases (psychiatric, hospital inpatient, hospice, nursing home).

Where the prescriber must be licensed

Florida license, or Florida out-of-state telehealth provider registration (456.47(4): active unencumbered license elsewhere, no discipline in 5 years, registered agent in Florida). (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. Georgia Board of Pharmacy rule 480-11-.02(5) says "Pharmacists shall ensure compliance with USP-NF standards for both sterile and non-sterile compounding." 480-11-.02(8): "Non-sterile compounded preparations shall be subject to USP 795. All sterile compounded preparations shall be subject to USP 797." 480-11-.02(12)(b) bans compounding "of any pharmaceutical products that are essentially copies of commercially available pharmaceutical products", with four exceptions (a prescriber-ordered change for one patient, the product is not available from the manufacturer or wholesaler, the product is on the drug shortages list, or mixing two or more commercial products). The Georgia statutes were not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear, see the official link. Official link

Official sources

• Official source 1
• Official source 2, archived copy, 2026-01-31

State rules for compounded drugs

Follows federal rules. HAR 16-95-110(a)(17): the board may discipline for "Failure to comply with the pharmaceutical compounding requirements found in chapters 795 (nonsterile preparations) and 797 (sterile preparations) of the United States Pharmacopeia National Formulary, as amended." No extra Hawaii limit on which drugs may be compounded was found in the rule text. (A confidence: medium) Hawaii note kept: HRS 453-1.3(c) is set to be repealed and reenacted Dec 31, 2027.

Telehealth before an in-person visit

Yes, with limits. HRS 453-1.3(b) requires a documented evaluation. 453-1.3(c) holds telehealth prescribing to the same standards as in person and says "Issuing a prescription based solely on an online questionnaire is not treatment." Opiates need an in-person consultation first, with a narrow 3-day exception inside the same medical group.

Where the prescriber must be licensed

Hawaii license required. 453-1.3(e): the relationship may be set up by telehealth only if the physician holds a Hawaii license. 453-2(a) requires a license. 453-2(b)(4) allows out-of-state consultation with a Hawaii physician. (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Stricter than federal. IDAPA 24.36.01 rule 700 says "Any compounding that is not permitted herein is considered manufacturing." Rule 700.02.a: "All active pharmaceutical ingredients must be obtained from an FDA registered manufacturer." Rule 700.04.b allows some drugs to be compounded only if "not compounded regularly or in inordinate amounts", with conditions. Rule 700.05.a points to USP chapters 795, 797, 1075 and 1160. Rule 700.03 covers drugs FDA withdrew and drugs with demonstrable difficulties. The rule version is from an archived copy, so a newer version was not checked. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes. Idaho Code 54-5705: a relationship "may be established by use of virtual care technologies" if the Idaho community standard of care is met. 54-5707(1): a provider may prescribe through virtual care. Controlled drugs only in compliance with federal law (21 U.S.C.).

Where the prescriber must be licensed

Idaho license required. 54-5713(1), with exceptions (a) to (f): patient temporarily in Idaho, short-term follow-up, contract with an Idaho facility, disaster, before a scheduled in-person visit, or consulting an Idaho provider. (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2, archived copy, 2025-05-30

State rules for compounded drugs

Stricter than federal. 68 Ill. Adm. Code 1330.640: sterile compounding for office use "is prohibited unless the pharmacy is in full compliance with 21 USC 353b" (outsourcing facility); sales of compounded drugs to other pharmacies, clinics, hospitals or manufacturers are "not allowed" except as listed; a compounding pharmacy must have an area used exclusively for compounding and a required label line. The same rule allows limited nonsterile office-use supply under listed conditions, which is a state allowance only. Compounding standards follow USP-NF (USP 47-NF 42). (A confidence: high) Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it.

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

License or permit required. 225 ILCS 60/49.5(b): practicing telemedicine without an Illinois license or permit brings penalties. 49.5(c) excludes periodic consults, second opinions, follow-up care after treatment in the provider's home state, and care for an existing patient who is traveling. (C confidence: high)

Extra telehealth limits

Unclear.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Yes, with limits. IC 25-1-9.5-8(a): a prescriber may prescribe by telehealth "if the patient has not been examined previously by the prescriber in person" when the standard of care is met. Opioids (except for opioid addiction treatment) and abortion drugs are barred by telehealth. 8(b): controlled drugs need live two-way audio-video plus DEA and INSPECT compliance. 25-1-9.5-6: an internet questionnaire or email is not telehealth unless a relationship already exists.

Where the prescriber must be licensed

Indiana license required. IC 25-1-9.5-3.5: a practitioner must hold an unlimited Indiana license. 25-22.5-8-1: practicing without a license is unlawful. 25-1-9.5-9: out-of-state practitioners are under Indiana jurisdiction. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1

State rules for compounded drugs

Stricter than federal. Iowa Code 155A.13C: an outsourcing facility that distributes sterile compounded drugs without a patient-specific prescription "shall obtain an outsourcing facility license from the board," and must hand in "any form 483s, warning letters, or formal responses" from FDA inspections with the application. The old board rules (657 ch. 20) were rescinded July 16, 2025, and the replacement compounding rules were not found, so rule-level limits are not read. (A confidence: medium) Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it.

Telehealth before an in-person visit

Yes, with limits. 481-655.9(7)(b)(3): a relationship may be set up through telemedicine "if the standard of care does not require an in-person encounter." 655.9(8): a static internet questionnaire is not acceptable for prescribing.

Where the prescriber must be licensed

Iowa license required. 481-655.9(3): "shall hold an active Iowa medical license," with exceptions listed in 481-652.2(2). (C confidence: medium)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Yes. K.S.A. 40-2,212(b): "Telemedicine may be used to establish a valid provider-patient relationship." (c): same standards as in person. (d): follow-up guidance, and a report to the primary care doctor within 3 business days with consent.

Where the prescriber must be licensed

Kansas license or telemedicine waiver. K.S.A. 65-28,135: a Kansas license, or a Board of Healing Arts telemedicine waiver (unrestricted out-of-state license, no investigation or discipline, fee up to $100, renewed yearly). (b): the doctor must document the medical reason for each prescription. (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

With limits. 201 KAR 2:076 Section 3(5): compounded drugs must meet a USP or National Formulary monograph, or be made from an ingredient of an FDA-approved drug, or from the FDA bulk substances list (21 C.F.R. 216.23). They may not be essential copies of a commercially available drug unless 21 U.S.C. 353a allows it. (A confidence: medium)

Telehealth before an in-person visit

Unclear if in-person first is required. KRS 311.597(1)(e) requires an identity check, a documented diagnosis, and a medical record, and says "an electronic, on-line, or telephonic evaluation by questionnaire is inadequate." No statute requiring an in-person visit first was found. KRS 311.5975 covers consent and privacy.

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. Act 374 of 2026 (SB 253, signed), which adds R.S. 37:23.5: no licensing board may stop a prescriber from giving patients peptides shipped from an FDA-registered 503B outsourcing facility that follows 21 U.S.C. 353b, or a 503A compounding pharmacy that follows 21 U.S.C. 353a and the applicable USP-NF chapters. Boards also may not stop a Louisiana pharmacist from compounding peptides under those same federal rules. The pharmacy must still follow federal compounding law, so the act does not make a peptide allowed if federal law does not allow it to be compounded (for example, a substance not on the federal bulk list). Act 374 only stops Louisiana boards from adding their own bans on top of federal law. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: high)

Telehealth before an in-person visit

Yes, with limits. R.S. 40:1223.4(B)(5): a provider "shall not be required to conduct an in-person patient history or physical examination" but must arrange follow-up care in Louisiana. (B)(2): same standard of care. (B)(7): audio-only allowed if the standard of care is met.

Where the prescriber must be licensed

License or registration under board rules. 40:1223.4(B)(3). The board's telemedicine permit rule (LAC 46:XLV.408) was not read. R.S. 37:1276.1 (the old telemedicine license) was repealed Jan 1, 2024. (C confidence: medium)

Extra telehealth limits

No controlled dangerous substance before an in-person history or exam, except under R.S. 37:1271.1 or board rule (40:1223.4(B)(6)). Nothing specific to compounded drugs found.

Official sources

• Official source 1

State rules for compounded drugs

Stricter than federal. Maine Board of Pharmacy rules, Chapter 3 section 7 (Compounding): non-sterile compounding needs no separate license "other than the general retail pharmacy license or closed-shop pharmacy license. A sterile compounding pharmacy must be separately licensed pursuant to Chapter 37 of the board's rules." A non-sterile compounding pharmacy "shall comply in all respects with United States Pharmacopeia USP 36-NF 31, General Chapter <795>" (the 2013-14 edition, a fixed older edition). Chapter 37 and 32 M.R.S. 13702-A(4) were not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with limits. Joint rule 02-373 Chapter 11: a relationship may be set up "through telehealth, if the standard of care does not require an in-person encounter." Before prescribing, the licensee must take a history and do a pertinent exam as the standard of care requires. A static internet questionnaire is not acceptable for prescribing.

Where the prescriber must be licensed

Maine license required. 32 MRSA 3270 requires a license to practice, including prescribing. Chapter 11 section 2(3)(A): physicians must hold an active Maine license or a Maine interstate registration. 32 MRSA 3300-D: that registration covers consultation only, requested by a Maine licensee. (C confidence: high)

Extra telehealth limits

None found in the rule text read.

Official sources

• Official source 1
• Official source 2
• Official source 3
• Official source 4

State rules for compounded drugs

Stricter than federal. COMAR 10.34.19.02 adopts USP 797 (sterile) and USP 795 (nonsterile) by reference, and the chapter adds state steps: COMAR 10.34.19.19 says a person that prepares and distributes sterile compounded medications for office use "shall hold: A. A manufacturer's permit or other permit designated by the U.S. Food and Drug Administration to ensure the safety of sterile compounded medications for office use" (plus a wholesale distributor permit if it applies). Only regulations .01, .02 and .19 were read; the other sections of chapter 19 (inspections, reporting) were not. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with limits. Health Occ. 1-1003(b): the practitioner must do a clinical evaluation fit for the patient before prescribing through telehealth, and may do it by live or recorded (asynchronous) telehealth. (a): same standards as in person. (c): Schedule II opiates for pain may not be prescribed by telehealth except in a facility, a declared emergency, or an ongoing relationship with a prior in-person assessment.

Where the prescriber must be licensed

Maryland license required. Health Occ. 14-301. 14-302 exceptions include consultation with a Maryland physician who keeps patient care. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Stricter than federal. 247 CMR 6.00 has separate licenses for sterile and complex non-sterile compounding pharmacies. 247 CMR 6.06(2): "The applicant shall achieve a satisfactory Board inspection of the proposed sterile compounding pharmacy prior to the issuance of an original sterile compounding pharmacy license." 6.07(2) says the same for a complex non-sterile compounding pharmacy license, and each license expires every December 31st. 247 CMR 9.01(3): "Unless otherwise regulated by the Board, a licensee shall adhere to the most current standards established by each chapter of the United States Pharmacopeia." The definitions of sterile and complex non-sterile compounding are in 247 CMR 2.00, which was not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Massachusetts license required. 243 CMR 2.01: the practice of medicine includes telemedicine. M.G.L. c.112 s.6: practicing medicine without registration is unlawful, except as provided in section 65 (not read). (C confidence: medium)

Extra telehealth limits

Unclear.

Official sources

• Official source 1
• Official source 2
• Official source 3
• Official source 4

State rules for compounded drugs

Stricter than federal. MCL 333.17748: a person that provides compounding services must be licensed as a pharmacy and "authorized to provide compounding services"; an outsourcing facility must be licensed as a pharmacy. MCL 333.17748a adds accreditation by "a national accrediting organization approved by the board" for sterile compounding pharmacies. MCL 333.17748b: a pharmacist or pharmacy "shall not compound nonsterile or sterile pharmaceuticals for a prescriber or health facility" to administer to patients without a prescription unless the drug complies with the most recent guidance under 21 USC 353a, and the state may authorize limited office-use quantities only on application. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes. MCL 333.16285(1): a health professional providing a telehealth service may prescribe a drug if acting within scope, and controlled drugs must meet the controlled substance rules. (2): referral if medically necessary, and follow-up care must be available. 333.16284: consent is required.

Where the prescriber must be licensed

License required. MCL 333.16294: practicing a regulated health profession without a license is a felony, except as provided in section 16215 (not read). (C confidence: medium)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. Minn. Rules 6800.3300 subpart 1: "All licensed Minnesota pharmacies that compound nonsterile drug preparations must follow United States Pharmacopeia, chapter 795, standards." Subpart 2: "Any licensed Minnesota pharmacy compounding a sterile product must follow the United States Pharmacopeia, chapter 797, standards." Subpart 6 adds that a pharmacy must keep a list of high-alert compounded preparations with a pharmacist check of each component (effective Jan 2, 2013), a small state add-on that does not change the label. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. Mississippi Board of Pharmacy regulations, Article XXXI (Compounding Guidelines): every permitted pharmacy that compounds and is not a licensed 503B outsourcing facility "shall comply with USP 795, USP 797, and USP 800 when compounding in the scope of those chapters." The pharmacy must get a "compounding certificate" from the Board and can be inspected. "Pharmacies shall not offer compounded human drug products to practitioners or to other pharmacies for resale or dispensing" (office-use limit); a pharmacy cannot compound drugs on the FDA withdrawn list or the demonstrable difficulties list. The Board's own notice says Article XXXI was amended effective April 12, 2024. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: high)

Telehealth before an in-person visit

Yes, with limits. Board rule 30-2635 Chapter 5, Rule 5.5: an exam is required before diagnosis and treatment, but "need not be in person if the technology is sufficient." Audio-only is allowed where medically appropriate. "A simple questionnaire without an appropriate exam" violates the rule. Rule 5.4 lists the relationship elements.

Where the prescriber must be licensed

Mississippi license required. Rule 5.2: "only providers holding a valid Mississippi license are allowed to practice telemedicine in Mississippi." (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. 20 CSR 2220-2.400 limits how much a pharmacy may batch: "Limited quantities, for purposes of this rule, are further defined as an amount of batched preparation that represents a three- (3-) month supply" (one year for external-use creams and similar). It also says "Pharmacists shall only receive, store, or use drug substances for compounding that have been made and/or distributed by Missouri licensed/registered drug distributors." 20 CSR 2220-2.200 for sterile compounding: "Except as otherwise provided by law or rule, licensees shall comply with all provisions of USP Chapter 797 and the additional requirements of this rule" (USP-NF 2023 edition, no later changes adopted). Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with limits. RSMo 191.1146.1(3): the relationship may be set up by "a telemedicine encounter, if the standard of care does not require an in-person encounter." 191.1146.2: a questionnaire counts only if reviewed by the treating professional and it gives information as if the evaluation were in person. 334.108: history, exam if the standard of care requires it, and a record, before prescribing.

Where the prescriber must be licensed

Missouri license required. RSMo 334.010: practicing medicine, including across state lines, without being a registered physician is unlawful, "except as herein provided" (exceptions not read). (C confidence: medium)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear.

Official sources

• Official source 1

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Yes. Neb. Rev. Stat. 38-1,143(1): a credential holder "may establish a provider-patient relationship through telehealth." (2): may prescribe a drug during a telehealth service if authorized under state and federal law.

Where the prescriber must be licensed

Nebraska credential required. 38-121(1)(y): no one may practice medicine and surgery without a credential under the Uniform Credentialing Act. 38-2024: prescribing counts as practicing medicine. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1

State rules for compounded drugs

Follows federal rules. NAC 639.670175: a pharmacist, pharmaceutical technician or dispensing practitioner who compounds in Nevada shall "comply with the compounding standards established in the publications and standards adopted by reference in subsection 1 of NAC 639.670" (which adopts the USP-NF, 2023 edition) and "Comply with all the requirements of 21 U.S.C. 353a, as applicable." Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes. NRS 629.515(4): a provider "may establish a relationship with a patient using telehealth when it is clinically appropriate."

Where the prescriber must be licensed

Nevada license required. NRS 629.515(1): a distant provider must hold a valid Nevada license or certificate, including a telemedicine license under NRS 630.261, before diagnosing or prescribing by telehealth. The only exception is care for an urban Indian organization. (3): the provider is under Nevada law and board rules. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear.

Official sources

• Official source 1

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Yes, with limits. N.J.S.A. 45:1-62 (P.L.2017, c.117, sec. 3), (d)(1): same standard of care as in person, and the provider must send the patient to in-person care if telehealth would not meet it. (d)(2): no prescription based only on an online questionnaire unless a proper provider-patient relationship exists.

Where the prescriber must be licensed

New Jersey license required. 45:1-62(b)(1): the provider must be "validly licensed, certified, or registered" in New Jersey. Exceptions for informal consults, specialist consults to a New Jersey provider, emergencies, and on-call coverage. (C confidence: medium)

Extra telehealth limits

Schedule II drugs only after an in-person exam, with an in-person visit every three months (45:1-62(e)), with a narrow exception for stimulants for minors. Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. No state list of allowed or banned substances found. 16.19.30 NMAC requires written procedures that follow USP 795. 16.19.30.9(E)(3): a pharmacist "may not compound a drug product which has been withdrawn or removed from the market for safety reasons." Copies of a commercial product only when it is not reasonably available and the prescriber asks. Sterile compounding follows USP 797 under 16.19.36 NMAC. (A confidence: high)

Telehealth before an in-person visit

Yes, with limits. 16.10.8.8(L) NMAC: prescribing with no established relationship, including online prescribing "based solely on an on-line questionnaire", is unprofessional conduct. 16.10.8.8(L)(6) allows care in a face-to-face video telehealth visit with a medical history, consent, and a record, where a physical exam is recorded by another practitioner or waived when it would not normally be part of the visit.

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules (no state compounding standard of its own found). Education Law 6802 defines compounding only for 503B outsourcing facilities. The pharmacy rules read (8 NYCRR Part 29 and Part 63) have no USP or 503A standard for regular pharmacies. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

New York license required. Education Law 6522: "Only a person licensed or otherwise authorized under this article shall practice medicine." (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. No state list of allowed or banned substances found. 21 NCAC 46 .2801(d) and (e) require USP 795 and USP 797. (c): office-use compounding "shall comply with applicable federal law." (A confidence: high)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

North Carolina license required. G.S. 90-18(a): practicing medicine without a North Carolina license is a crime, and a Class I felony for an out-of-state practitioner. 90-18(c)(18) exempts care for a doctor's own regular patient who is temporarily in North Carolina. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. No state list of allowed or banned substances found. NDAC 61-02-01-03 requires USP 795, 797, 800, and 1160, and bans compounding drugs on the federal withdrawn or removed list. (A confidence: high)

Telehealth before an in-person visit

Yes, with limits. NDCC 43-17-44(3): an exam "may be performed entirely through telemedicine" if it is equal to an in-person exam. A static online questionnaire or an audio-only call does not meet the standard. 43-17-45(1): after a proper telemedicine exam the licensee may prescribe.

Where the prescriber must be licensed

North Dakota license required. NDCC chapter 43-17: "A practitioner providing medical care to a patient located in this state ... shall possess an active North Dakota license." (C confidence: high)

Extra telehealth limits

Opioids only for FDA-approved addiction treatment or hospital and long-term care patients (43-17-45(1)). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. No state list of allowed or banned substances found in the rule read. OAC 4729:7-2-03 (effective March 7, 2024): (A) and (B) require USP compliance, (E) "Comply with Title 21 U.S. Code section 353a," (I) patient-specific prescription, and (Q) FDA warning letters must be reported to the board. (A confidence: high)

Telehealth before an in-person visit

Yes, for drugs that are not controlled. ORC 4731.74(B)(1): board rules must let a physician set up a relationship by technology that meets the in-person standard of care. OAC 4731-11-09(B) and (C): controlled drugs must follow federal law and telehealth rule 4731-37-01. (D): Schedule II needs an in-person exam for a new patient, with exceptions in (E).

Where the prescriber must be licensed

Ohio license required. ORC 4731.41(A): "No person shall practice medicine and surgery ... without the appropriate license or certificate from the state medical board." (C confidence: high)

Extra telehealth limits

Schedule II limits in OAC 4731-11-09(D). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Stricter than federal. 59 O.S. 353.18(A)(4): "A retail pharmacy that prepares sterile drugs shall obtain a pharmacy license, and shall also obtain a sterile compounding permit at a fee set by the Board." 353.18(A)(5): "An outsourcing facility desiring to dispense prescriptions to patients must additionally license and meet the requirements of a pharmacy." The Board sets the sterile permit requirements by rule, and those rules were not read (the two OAC 535:15-10 copies read on 2026-09-26 only matched USP wording and are undated). Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes. 59 O.S. 478.1(A): a physician may set up a valid relationship with a patient in Oklahoma through telemedicine if licensed in Oklahoma, confirms the patient's identity and location, and gives the patient their credentials.

Where the prescriber must be licensed

Oklahoma license required. 59 O.S. 478.1(A)(1). (C confidence: high)

Extra telehealth limits

No opiates, benzodiazepines, or one other drug named in the official rule from a telemedicine-only relationship, except addiction treatment drugs (478.1(C)). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. The board's 2026 Compounding Pharmacy Self-Inspection Form cites OAR 855-045-0200 and 0205 for USP chapters, asks whether bulk drug substances come from registered sources with a certificate of analysis (citing federal 503A and 503B guidance), and asks whether only ingredients approved for human use, not lab or research grade, are used. (A confidence: medium)

Telehealth before an in-person visit

Yes. ORS 677.494(2): a licensed physician may use telemedicine to set up a provider-patient relationship, diagnose, and prescribe for a patient in Oregon, and need not be in Oregon.

Where the prescriber must be licensed

Oregon license, or an Oregon license to practice across state lines. ORS 677.494(2) and (3): practice happens where the patient is. ORS 677.137 and 677.139. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. 49 Pa. Code 27.601: compounding "shall be done in accordance with section 503a of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.A. § 353a), Federal regulations ... and the current version of the USP chapters." (A confidence: high)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Follows federal rules. 216-RICR-40-15-1 (effective April 12, 2026) adopts USP 795 and 797 (2023) and USP 800, and says compounding "does not mean ... drug products that are essentially copies of a commercially available product." (A confidence: high)

Telehealth before an in-person visit

Yes, with limits. 216-RICR-40-05-1: telemedicine prescribing is held to the same standards as face to face. Prescribing "based solely on an online questionnaire without an appropriate evaluation" is unprofessional conduct, and asynchronous evaluation without a real-time exchange "is not appropriate."

Where the prescriber must be licensed

Rhode Island license required. 216-RICR-40-05-1 section 1.3.1(A) and R.I. Gen. Laws 5-37-12. (C confidence: high)

Extra telehealth limits

Real-time exchange required (no asynchronous-only evaluation). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Looser than federal (fewer state rules of its own). Act 132 of 2024 (H.3592, signed May 13, 2024) amended S.C. Code 40-43-86(CC). (c) allows compendial substances, or chemically pure, analytical reagent, or ACS grade, "or ... drug substances that meet the accepted standard of the practice of pharmacy." (d): "first attempt" to use FDA-registered components, otherwise professional judgment with a certificate of analysis. Until the board adopts new rules, pharmacies follow the board's compounding inspection forms, which were not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with limits. S.C. Code 40-47-37(C)(2): the evaluation "need not be done in person" if the licensee can diagnose and treat to the standard of care by telehealth. 40-47-113(B) allows prescribing in a telemedicine-only relationship that follows 40-47-37. 40-47-113(C): prescribing based only on answers to a set of questions is unprofessional.

Where the prescriber must be licensed

South Carolina license required. 40-47-37(A)(4), with narrow exceptions for informal consults and ongoing out-of-state specialty care. (C confidence: high)

Extra telehealth limits

No Schedule II or III narcotics by telemedicine except in listed cases (40-47-37(C)(7)(b)). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Follows federal rules. ARSD 20:51:31:32: all sterile and nonsterile compounding "must be handled in accordance with federal law, this chapter, and the United States Pharmacopeia" (USP chapters 795, 797, 800, 825). (A confidence: high)

Telehealth before an in-person visit

Yes, with conditions. SDCL 34-52-3: a proper provider-patient relationship must be set up by telehealth, including a diagnosis using history and exam. 34-52-5: a face-to-face exam using real-time audio and video is needed before diagnosis and treatment if a face-to-face visit would otherwise be required.

Where the prescriber must be licensed

South Dakota license required. SDCL 34-52-2: must be "fully licensed to practice in the state," or employed by one of the listed licensed facilities or agencies. (C confidence: high)

Extra telehealth limits

SDCL 34-52-6: no controlled drug from an internet questionnaire or phone consult alone without a proper relationship. Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Stricter than federal. Board of Pharmacy rule 1140-07-.02(1) says compounded drug products "shall comply with the standards established by United States Pharmacopeia ("USP") chapters 795, 797, 800, and/or 825" including later amendments and editions, and 1140-07-.02(3) says not following it "shall be considered unprofessional conduct". Rule 1140-01-.12 says no licensee may compound any sterile product to be dispensed in or from Tennessee "without first obtaining a sterile compounding modifier registration from the Board of Pharmacy". The Board can waive USP requirements for good cause (1140-07-.02(2)). Tennessee Code Title 63 chapter 10 was not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear, see the official link. Official link

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Stricter than federal. Texas Occupations Code 562.152: "A pharmacy may dispense and deliver a reasonable quantity of a compounded drug to a practitioner for office use by the practitioner in accordance with this chapter." Section 562.153 says to do that the pharmacy must "verify the source of the raw materials to be used in a compounded drug", follow United States Pharmacopoeia guidelines including testing, meet Board competency and accrediting standards, and "comply with board rules, including rules regarding the reporting of adverse events by practitioners and recall procedures for compounded products." The Board rules (22 TAC 291.131 and 291.133) were not read in full. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Unclear, see the official link. Official link

Extra telehealth limits

Unclear, see the official link. Official link

Official sources

• Official source 1
• Official source 2
• Official source 3
• Official source 4, archived copy, 2025-12-05

State rules for compounded drugs

Stricter than federal. Utah Code 58-17b-306(1)(i): an applicant for a pharmacy license that engages in compounding must "submit the most recent inspection report" from the past two years, done through the NABP Verified Pharmacy Program or by the home state's licensing agency, and 58-17b-308 requires the same at renewal for a class D pharmacy that compounds. 58-17b-502(1)(m) makes it unprofessional conduct to compound "a prescription drug in a dosage form which is commonly available from a manufacturer in quantities and strengths a practitioner prescribes." The pharmacy rule R156-17b was still not read. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with conditions. Utah Code 26B-4-704(2): if there is no relationship yet, the provider must set one up during the visit, and before prescribing must "establish a diagnosis" after getting and documenting the relevant clinical history. (4): no diagnosis, treatment, or prescription based only on an online questionnaire, an email, or a patient-generated medical history. Telemedicine covers two-way audio-video or store-and-forward.

Where the prescriber must be licensed

Utah license required. Utah Code 58-67-301(1): a license is required to practice medicine "on or for any person in Utah." 26B-4-704(5)(b): the license must be active and in good standing. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found. The Division's rule on how to set up the relationship was not read.

Official sources

• Official source 1
• Official source 2
• Official source 3
• Official source 4

State rules for compounded drugs

Stricter than federal. Vermont Office of Professional Regulation pharmacy rules, rule 10-4: "A pharmacy that performs compounding must register as a compounding pharmacy in addition to being licensed as a retail pharmacy." "A compounding pharmacy must comply with all applicable law and USP chapters, including 21 U.S.C. § 353a, USP <795> for non-sterile compounding, USP <797> for sterile compounding, and USP <800> for compounding of hazardous drugs." Compounding must be done on a practitioner's patient-specific order, in limited quantities for a specific patient based on prescribing history, or for veterinary use. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: high)

Telehealth before an in-person visit

Yes. 18 V.S.A. 9361(b): a Vermont-licensed provider may prescribe after "an appropriate examination of the patient in person, through telemedicine," or by transmitted images and records. Prescriptions are held to the same standards as in-person care. 9361(c) requires documented informed consent for telemedicine.

Where the prescriber must be licensed

Vermont license, or a Vermont telehealth license or telehealth registration, required. 26 V.S.A. 3053(a) and (c): an out-of-state professional treating a patient in Vermont by telehealth without one is engaged in unauthorized practice. 26 V.S.A. 1314 makes practice without a license illegal. (C confidence: high)

Extra telehealth limits

A telehealth license or registration allows telehealth only, not an office or in-person care in Vermont (3053(b)). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3
• Official source 4

State rules for compounded drugs

Looser than federal (fewer state rules of its own). Va. Code 54.1-3410.2(E) requires USP-NF standards for sterile and nonsterile compounding. (F)(1) allows bulk drug substances that meet a USP or NF monograph, are parts of FDA-approved drugs, are otherwise FDA-approved, "or are manufactured by an establishment that is registered by the FDA." The last option is wider than the federal list of allowed bulk substances. Copies of commercial products are banned with exceptions. Federal law still applies: a state rule cannot make a drug allowed to compound when federal law does not allow it. (A confidence: medium)

Telehealth before an in-person visit

Yes, with conditions. Va. Code 54.1-3303: a bona fide relationship for Schedule II to VI drugs may be set up by real-time face-to-face or store-and-forward exam if conditions are met, including a medical history, a diagnosis at the time of prescribing, an active Virginia license, and "the standard of care does not require an in-person examination." Schedule VI covers all other prescription drugs.

Where the prescriber must be licensed

Virginia license required. Va. Code 54.1-2902: unlawful to practice medicine "in the Commonwealth without a valid unrevoked license." 54.1-3303 also requires an active Virginia license for telemedicine prescribing. (C confidence: high)

Extra telehealth limits

For Schedule II to V by telemedicine, the prescriber must keep a practice location in Virginia or be able to refer the patient for an in-person exam (54.1-3303). Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Follows federal rules. WAC 246-945-100(1): licensees must follow USP 795 and 797 (official Nov 1, 2023), 800, and 825. (A confidence: high)

Telehealth before an in-person visit

Yes. RCW 18.134.030(3): "A practitioner-patient relationship may be established through telehealth," but not by email, instant message, text, or fax. RCW 18.134.040(1): the same practice standards as in-person care apply, including for prescribing.

Where the prescriber must be licensed

Washington license required. RCW 18.71.021: no one may practice medicine "without first having a valid license." RCW 18.134.050: an out-of-state practitioner needs a Washington license or compact authority, except for narrow consult and specialty-assessment cases that do not include treatment. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Follows federal rules. 15 CSR 1 (effective July 1, 2026) 11.1.2: all USP standards are the minimum standards for all pharmacists and pharmacies. 12.1.2: sterile compounding is subject to state rules "and all Federal laws and regulations." 12.3: sterile rooms must meet USP 797 and 800 (2023). (A confidence: high)

Telehealth before an in-person visit

Yes, with conditions. W. Va. Code 30-3-13a(c)(2): a new relationship may be set up by interactive audio with store-and-forward, real-time video, or real-time audio-only calls. (c)(1): not by email, internet questionnaire, text, or other written forms. (e): no prescription based only on an online questionnaire.

Where the prescriber must be licensed

West Virginia license or registration required. 30-3-13a(b)(2): a physician practicing telemedicine must be licensed under the article or registered under 30-1-1 et seq. 30-3-13(a) makes practice without an active license unlawful. (C confidence: high)

Extra telehealth limits

30-3-13a(g): no Schedule II controlled drugs to a telemedicine-only patient (except established patients and listed groups), and no Schedule II pain drugs for chronic nonmalignant pain by telemedicine alone. Nothing specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2
• Official source 3

State rules for compounded drugs

Follows federal rules. Wis. Admin. Code Phar 15.02 (new chapter effective Oct 1, 2025) adopts USP 795 and 797 (official Nov 1, 2023) and USP 800. The only change is a narrow flavoring exception. (A confidence: high)

Telehealth before an in-person visit

Yes, with conditions. Med 24.03: "A physician-patient relationship may be established through telemedicine." Med 24.07(1): before prescribing through a website, the physician needs a Wisconsin license, informed consent, a documented evaluation with medical history, and a record. Med 24.07(2): prescribing based only on a static online questionnaire is below the standard of care.

Where the prescriber must be licensed

Wisconsin license required. Med 24.04: a physician using telemedicine for a patient in Wisconsin "shall be licensed" by the medical examining board. (C confidence: high)

Extra telehealth limits

None specific to compounded drugs found.

Official sources

• Official source 1
• Official source 2

State rules for compounded drugs

Unclear, see the official link. Official link

Telehealth before an in-person visit

Unclear, see the official link. Official link

Where the prescriber must be licensed

Wyoming license required. Wyo. Stat. 33-26-301(a): "No person shall practice medicine in this state without a license granted by the board, or as otherwise provided by law." Telemedicine is the practice of medicine (33-26-102(a)(xxix)). (C confidence: high)

Extra telehealth limits

Unclear, see the official link. Official link

Official sources

• Official source 1
• Official source 2